Medicago IncTSX/Alpha:MDGview on OTCQX International »
Symbol Lookup
Refresh
Recent News»
0 New Today| Company | Market Cap | P/E Ratio (TTM) | EPS Growth (5yr) | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Oncolytics Biotech Inc ONC | 237.3M | -- | -- | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| EnWave Corp ENW | 125.5M | -- | -- | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Trimel Pharmaceuticals Corp TRL | 117.9M | -- | -- | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Resverlogix Corp RVX | 268.4M | -- | -- | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Neptune Technologies & Bioressources Inc NTB | 176.7M | -- | -- | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Data delayed 15 minutes. | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Company Information
Medicago Inc (Medicago) is a clinical-stage biotechnology company. The Company is focused on the development of vaccines using its Virus-Like Particules (VLPs) and manufacturing technologies. Medicago's VLP manufacturing technology is based on a transient expression system, which produces recombinant vaccine antigens in non-transgenic plants. Medicago operates a 24,000-square-foot production facility located in the Technology Park in Quebec City, Canada. This facility includes a Biosafety level 2 greenhouse, an extraction and purification unit, and is cGMP compliant. The Company's products include Pandemic flu vaccine and Seasonal flu vaccine. Medicago U.S.A is a wholly owned subsidiary of Medicago.
| Headquarters | Bureau 600, 1020, route de l'glise QUEBEC, QC, Canada G1V 3V9 |
|---|---|
| Phone | 418-658-9393 |
| Fax | 418-658-6699 |
EXECUTIVE OFFICERS
| Independent Chairman of the Board | Randal Chase |
|---|---|
| President, Chief Executive Officer, Director | Andrew Sheldon |
| Chief Financial Officer, Vice President | Pierre Labbe |
| Executive Vice President - Operations | Michael Wanner |
| Vice President - Quality Assurance and Quality Control | Brigitte Barbeau |
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
With TD Waterhouse, you have access to the industry's leading selection of independent research reports from providers such as TDSI, TD Securities, S&P, INK and Argus.
Open a New Account, or Login if you're a client.
(GAAP)*
| Market Cap | $183.4M | Beta | 1.28 |
|---|---|---|---|
| Revenue (TTM) | $5.3M | EPS | $-0.12 |
| Shares Out. | 254.7M | Book Value | $0.15 |
| Dividend Yield | 0.00% | P/E | -- |
| Annual Dividend Rate | $0.00 | Price/Sales (TTM) | 34.3 |
| Ex-Div Date | 1/1/01 | P/Cash Flow (TTM) | -- |
| Pay Date | 1/1/01 | Operating Margin | -532.80% |
*GAAP = prior to non-GAAP analyst adjusted earnings.
(Non-GAAP)*
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
